Cat Feline Infectious Peritonitis Pathophysiology and Welfare

Understanding FIP's complex immune-mediated pathophysiology has been essential to developing the antiviral treatments that transformed this once-fatal disease.

Key Facts

FIP results from a mutation in feline enteric coronavirus that allows systemic spread and immune dysregulation
Wet FIP causes effusion in body cavities from vasculitis, while dry FIP causes granulomas in organs
The wet form causes rapid deterioration from fluid accumulation compressing lungs and abdominal organs
Nucleoside analog antivirals inhibit viral replication and allow immune recovery in treated cats
Treatment response is often dramatic with cats improving visibly within days of starting antiviral therapy

Welfare Considerations

FIP before effective treatment caused extreme suffering through respiratory compromise from pleural effusion, abdominal distension, neurological dysfunction from CNS involvement, and progressive systemic failure. The disease struck predominantly young cats between 6 months and 2 years, causing welfare emergencies in animals at the beginning of their lives. The development of antiviral treatment represents a paradigm shift from palliative euthanasia to curative treatment. Cats treated for FIP show rapid return to normal behavior, weight gain, and resolution of effusion within weeks, with long-term remission in the majority of treated animals. Welfare monitoring during treatment includes regular assessment of effusion, neurological status, and protein levels.

What You Can Do

Seek immediate diagnosis if your young cat shows rapid deterioration with abdominal distension or fluid
Access antiviral treatment through your veterinarian as soon as FIP diagnosis is confirmed
Monitor treated cats monthly for signs of relapse in the 3-6 months after completing treatment
Support organizations advocating for affordable FIP treatment access globally